 BOULDER, Colo.--BUSINESS WIRE--- BDSX patientsfirst--Biodesix, Inc. Nasdaq: BDSX, a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will present virtually at the H.C. Wainwright Global Investment Conference being held May 23-25, 2022. H.C. Wainwright Global Investment Conference Date: Tuesday, May 24, 2022 Pre-recorded on-demand presentation available beginning at 7:00 AM ET The on-demand presentation will be availa 